Видео ютуба по тегу Event: Esmo Breast 2022

Immunotherapy insights from ESMO Breast 2022
Immunotherapy insights from ESMO Breast 2022
Emergence of antibody-drug conjugates in metastatic breast cancer: 2022 ESMO Florida
Emergence of antibody-drug conjugates in metastatic breast cancer: 2022 ESMO Florida
Exciting developments in ADCs for BC presented at ESMO Breast 2022
Exciting developments in ADCs for BC presented at ESMO Breast 2022
Key lectures from ESMO Breast Cancer 2022
Key lectures from ESMO Breast Cancer 2022
Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE, VIKTORIA1, evERA, DESTINY, ASCENT, TROPION
Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE, VIKTORIA1, evERA, DESTINY, ASCENT, TROPION
Highlights from ESMO Breast Cancer 2022
Highlights from ESMO Breast Cancer 2022
How to Make Sense of Breast Cancer Data from ESMO 2025
How to Make Sense of Breast Cancer Data from ESMO 2025
“Moving the needle” in the metastatic breast cancer setting: 2022 ESMO Florida
“Moving the needle” in the metastatic breast cancer setting: 2022 ESMO Florida
Refining Classification and Staging in Breast Cancer – Biology Matters Alot: 2022 ESMO Florida
Refining Classification and Staging in Breast Cancer – Biology Matters Alot: 2022 ESMO Florida
Breast and gynecological cancer highlights at ESMO Immuno-Oncology 2022
Breast and gynecological cancer highlights at ESMO Immuno-Oncology 2022
Advances in antibody-drug conjugates for breast cancer at ESMO 2022
Advances in antibody-drug conjugates for breast cancer at ESMO 2022
ESMO Breast 2021 highlights
ESMO Breast 2021 highlights
Breast cancer trials of interest at ESMO 2022
Breast cancer trials of interest at ESMO 2022
Highlights in breast cancer at ESMO 2024: KEYNOTE-522
Highlights in breast cancer at ESMO 2024: KEYNOTE-522
Clincal trial highlights in breast cancer at ESMO 2022
Clincal trial highlights in breast cancer at ESMO 2022
Key takeaways in breast cancer from ESMO 2022
Key takeaways in breast cancer from ESMO 2022
ESMO Breast Cancer 2026 - Call for abstracts
ESMO Breast Cancer 2026 - Call for abstracts
Highlights from ESMO Breast 2021
Highlights from ESMO Breast 2021
#ESMO22 Highlights on abemaciclib + NSAI in HR+/HER2- advanced breast cancer: The MONARCH 3 study
#ESMO22 Highlights on abemaciclib + NSAI in HR+/HER2- advanced breast cancer: The MONARCH 3 study